PHARMASOVA: what changed
What changed
PHARMASOVA
NACE 64.210, Activities of holding companies
filed annual accounts (NBB)
Net result for the year
€1.9m
2024 · €1.5m+€370,827
Equity
€27.9m
2024 · €27.8m+€100,243
Cash
€89,797
2024 · €173,966-€84,170
Balance sheet total
€38.9m
2024 · €39.1m-€128,443
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
No liability line moved by more than 1% of the balance sheet total.
Income statement
- Financial income +€389,000
up €389,000 (+24.6%), from €1.6m to €2.0m
- Gross operating margin -€10,002
down €10,002 (-10.8%), from €92,829 to €82,828
- Financial charges +€7,835
up €7,835 (+4.1%), from €191,852 to €199,687
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€1.5m
Gross operating margin
-€10,002
Other operating charges
-€7
Other operating items
-€330
Financial income
+€389,000
Financial charges
-€7,835
Result 2025
€1.9m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.7m
Investment
€0
Financing
-€1.8m
Cash 2024
€173,966
From operations (derived)
+€1.7m
Net result for the year
+€1.9m
Receivables within one year
+€44,273
Smaller working-capital items
+€2,103
Other debts
-€230,789
Financing
-€1.8m
Contributions, distributions and other
-€1.8m
Cash 2025
€89,797
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €39,050,167 | €38,921,724 | -€128,443 | -0.3% |
| Fixed assets | 21/28 | €36,804,801 | €36,804,801 | = | 0.0% |
| Financial fixed assets | 28 | €36,804,801 | €36,804,801 | = | 0.0% |
| Current assets | 29/58 | €2,245,366 | €2,116,923 | -€128,443 | -5.7% |
| Amounts receivable within one year | 40/41 | €2,071,400 | €2,027,127 | -€44,273 | -2.1% |
| Trade receivables | 40 | €189,914 | €89,399 | -€100,515 | -52.9% |
| Other amounts receivable | 41 | €1,881,486 | €1,937,727 | +€56,242 | +3.0% |
| Cash at bank and in hand | 54/58 | €173,966 | €89,797 | -€84,170 | -48.4% |
| Total equity and liabilities | 10/49 | €39,050,167 | €38,921,724 | -€128,443 | -0.3% |
| Equity | 10/15 | €27,828,726 | €27,928,969 | +€100,243 | +0.4% |
| Contributions | 10/11 | €6,337,309 | €6,337,309 | = | 0.0% |
| Capital | 10 | €6,337,309 | €6,337,309 | = | 0.0% |
| Issued capital | 100 | €6,337,309 | €6,337,309 | = | 0.0% |
| Reserves | 13 | €19,347,725 | €19,440,325 | +€92,600 | +0.5% |
| Non-distributable reserves | 130/1 | €289,900 | €382,500 | +€92,600 | +31.9% |
| Legal reserve | 130 | €289,900 | €382,500 | +€92,600 | +31.9% |
| Distributable reserves | 133 | €19,057,825 | €19,057,825 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,143,692 | €2,151,335 | +€7,643 | +0.4% |
| Amounts payable | 17/49 | €11,221,441 | €10,992,755 | -€228,686 | -2.0% |
| Amounts payable after more than one year | 17 | €9,085,420 | €9,085,420 | = | 0.0% |
| Financial debts | 170/4 | €7,085,420 | €7,085,420 | = | 0.0% |
| Other amounts payable | 178/9 | €2,000,000 | €2,000,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €2,136,021 | €1,907,335 | -€228,686 | -10.7% |
| Financial debts | 43 | €1,000,000 | €1,000,000 | = | 0.0% |
| Credit institutions | 430/8 | €1,000,000 | €1,000,000 | = | 0.0% |
| Trade debts | 44 | €3,750 | €2,980 | -€770 | -20.5% |
| Suppliers | 440/4 | €3,750 | €2,980 | -€770 | -20.5% |
| Taxes, remuneration and social security | 45 | €6,602 | €9,475 | +€2,873 | +43.5% |
| Taxes | 450/3 | €6,602 | €9,475 | +€2,873 | +43.5% |
| Other amounts payable | 47/48 | €1,125,669 | €894,880 | -€230,789 | -20.5% |
| Other operating charges | 640/8 | €960 | €968 | +€7 | +0.8% |
| Non-recurring operating charges | 66A | - | €330 | +€330 | |
| Gross operating margin | 9900 | €92,829 | €82,828 | -€10,002 | -10.8% |
| Operating profit (loss) | 9901 | €91,869 | €81,530 | -€10,339 | -11.3% |
| Financial income | 75/76B | €1,581,000 | €1,970,000 | +€389,000 | +24.6% |
| Recurring financial income | 75 | €1,581,000 | €1,970,000 | +€389,000 | +24.6% |
| Financial charges | 65/66B | €191,852 | €199,687 | +€7,835 | +4.1% |
| Recurring financial charges | 65 | €191,852 | €199,687 | +€7,835 | +4.1% |
| Profit (loss) for the period before taxes | 9903 | €1,481,017 | €1,851,843 | +€370,827 | +25.0% |
| Profit (loss) for the period | 9904 | €1,481,017 | €1,851,843 | +€370,827 | +25.0% |
| Profit (loss) for the period to be appropriated | 9905 | €1,481,017 | €1,851,843 | +€370,827 | +25.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.